RenovoRx, Inc.
RNXT—
RenovoRx, Inc.RNXT$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-0.32
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$1.12M
Net income
$-11.17M
Net margin
-994.5%
Gross margin
70.9%
Dividends & financials
RenovoRx, Inc. (RNXT) reported revenue of $1.12M and net income of $-11.17M, or $-0.32 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.